当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock – a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC)
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2022-07-22 , DOI: 10.1002/ejhf.2629
Marco Metra 1 , Ovidiu Chioncel 2, 3 , Gad Cotter 4, 5 , Beth Davison 4, 5 , Gerasimos Filippatos 6 , Alexandre Mebazaa 5, 7 , Maria Novosadova 4 , Piotr Ponikowski 8 , Phillip Simmons 9 , Joseph Soffer 9 , Steven Simonson 9
Affiliation  

We examined the effects of istaroxime in patients hospitalized for acute heart failure (AHF) related Society for Cardiovascular Angiography and Interventions (SCAI) stage B pre-cardiogenic shock (CS).

中文翻译:

Istaroxime 在急性心力衰竭相关心源性休克患者中的安全性和有效性——一项多中心、随机、双盲、安慰剂对照、平行组研究 (SEISMiC)

我们检查了伊司他肟对因急性心力衰竭 (AHF) 相关的心血管造影和干预协会 (SCAI) B 期心源性休克前 (CS) 住院患者的影响。
更新日期:2022-07-22
down
wechat
bug